O. Varenne

Publication List Details

Period

1995 - 2001

Number

11

Co-Authors

L-arginine administration reduces neointima formation after stent injury in rats by a nitric oxide-mediated mechanism (2001)

Nong, Z, Stabile, E, Varenne, O, Gillijns, H, ...

The clinical outcome of vascular stenting is limited by in-stent stenosis. Increased nitric oxide (NO)/cGMP signaling by L-arginine (L-Arg) supplementation, the substrate for NO synthase (NOS), or...

Soluble guanylate cyclase alpha(1) and beta(1) gene transfer increases NO responsiveness and reduces neointima formation after balloon injury in rats via antiproliferative and antimigratory effects (2001)

Chiche, J D, Nong, Z, Varenne, O, Van Pelt, N, Gillijns, H, ...

In vascular smooth muscle cells, NO stimulates the synthesis of cGMP by soluble guanylate cyclase (sGC), a heterodimer composed of alpha(1) and beta(1) subunits. NO/cGMP signal transduction affects...

Gene therapy in the cardiovascular system: an update (1999)

Varenne, O, Janssens, S

This update reviews the remarkable progression in several cardiovascular gene transfer domains. The first chemical gene therapy protocols to stimulate angiogenesis in ischemic myocardium are...

Human endothelial nitric oxide synthase gene transfer inhibits vascular smooth muscle cell proliferation and neointima formation after balloon injury in rats (1998)

Flaherty, D, Nong, Z, Varenne, O, Van Pelt, N, ...

BACKGROUND: Loss of endothelial NO production after arterial injury may contribute to restenosis, characterized by neointima formation and elastic recoil. Adenovirus-mediated transfer of the gene...

Surgical treatment of infective endocarditis (1995)

Acar, J., Michel, P. L., Varenne, O., Michaud, P., Rafik, T.

Optimal timing of surgery in infective endocarditis (IE) depends mainly on the haemodynamic tolerance of the patient. Emergency surgery is required in cases of refractory heart failure due to...